№ files_lp_4_process_1_47927
File format: docx
Character count: 37006
File size: 344 KB
The document outlines a medical protocol for accreditation procedures regarding the examination of specimens from patients with retinoblastoma, specifying required data elements for synoptic reporting.
Year:
2021
Region / City:
Not specified
Topic:
Medical protocol, Retinoblastoma
Document Type:
Protocol
Organization / Institution:
CAP
Author:
Tatyana Milman, MD; Hans E. Grossniklaus, MD, MBA; Ralph C. Eagle, Jr., MD; Patricia Chevez-Barrios, MD; Dan S. Gombos, MD, FACS
Target Audience:
Pathologists, Medical professionals
Period of Validity:
Until March 2022
Approval Date:
June 2021
Revision Date:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2017
Region / City:
N/A
Topic:
Retinoblastoma, Germ Cell Tumors, Hepatoblastoma
Document Type:
Medical Case Study
Organization / Institution:
N/A
Author:
Carlos Rodriguez-Galindo, MDA
Target Audience:
Medical Professionals
Period of Action:
N/A
Approval Date:
N/A
Modification Date:
N/A
Version:
1.5.0.0
Protocol Posting Date:
June 2024
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2025
Authors:
Gulisa Turashvili, MD, PhD; Uma G. Krishnamurti, MD, PhD; Barbara A. Crothers, DO; Giovanna A. Giannico, MD; Krisztina Hanley, MD; Anna Plotkin, MD; Anthony N. Karnezis, MD, PhD.
Note:
Accreditation Requirements
Date of Protocol Posting:
June 2024
Date of Required Use:
March 2025
Year:
2010
Region / City:
Grahamstown
Subject:
Biomaterials transfer, research agreements
Document Type:
Agreement
Organization / Institution:
South African Institute for Aquatic Biodiversity (SAIAB)
Author:
SAIAB Collections Manager
Target Audience:
Researchers, research institutions
Effective Period:
Not specified
Approval Date:
18 March 2010
Modification Date:
Not specified
Context:
Legal agreement for the transfer of biomaterials from SAIAB collections to researchers for research purposes.
Year:
2026
Region / City:
Alberta, Canada
Theme:
Paleontology, Dinosaur Anatomy
Document Type:
Research Article
Institution:
University of Calgary, Royal Tyrrell Museum of Palaeontology
Author:
Jared T. Voris, Darla K. Zelenitsky, François Therrien, Ryan C. Ridgely, Philip J. Currie, Lawrence M. Witmer
Target Audience:
Paleontologists, Researchers in Evolutionary Biology
Period of Activity:
Cretaceous Period
Approval Date:
2026
Date of Revisions:
None specified
Year:
2021
Region / City:
International
Topic:
Soft tissue sarcoma histopathology
Document Type:
Guide
Organization / Institution:
International Collaboration on Cancer Reporting (ICCR)
Author:
Not specified
Target Audience:
Pathologists, oncologists, medical professionals
Effective Period:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Version:
4.4.0.0
Protocol Posting Date:
June 2021
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2022
Authors:
Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Note:
Accreditation Requirements
Year:
2021
Region / City:
Global
Theme:
Oncology, Breast Cancer
Document Type:
Protocol
Organization / Institution:
CAP (College of American Pathologists)
Author:
Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Target Audience:
Medical professionals, pathologists
Period of Validity:
From March 2022
Date of Approval:
June 2021
Date of Changes:
June 2021
Year:
2024
Region / City:
Not specified
Subject:
Pathology, Oncology
Document Type:
Protocol
Organization / Institution:
CAP (College of American Pathologists)
Author:
Uma G. Krishnamurti, MD, PhD; Kimberly H. Allison, MD; Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Target Audience:
Pathologists, Medical Institutions
Period of Validity:
March 2025
Approval Date:
Not specified
Date of Last Change:
June 2024
Version:
4.2.0.1
Protocol Posting Date:
June 2022
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2022
For accreditation purposes:
Surgical resection, including esophagectomy and esophagogastrectomy; Epithelial tumors of the esophagus, and esophagogastric junction with tumor involvement of no more than 2 cm into the proximal stomach.
Authors:
Lawrence J. Burgart, MD; William V. Chopp, MD; Dhanpat Jain, MD
Synoptic Reporting:
Core and conditional data elements must be reported in a synoptic format for accreditation.
Case Summary:
Esophagus
Histologic Type:
Adenocarcinoma, Squamous cell carcinoma, Neuroendocrine carcinoma, among others.
Version:
1.2.0.0
Protocol posting date:
March 2023
Document type:
Clinical pathology protocol
Medical field:
Breast pathology, oncology
Procedures covered:
Needle biopsy, fine needle aspiration, other biopsy procedures
Tumor types included:
Invasive breast carcinoma of any type, with or without ductal carcinoma in situ
Tumor types excluded:
Ductal carcinoma in situ without invasion, Paget disease without invasion, phyllodes tumor, lymphoma, sarcoma
Authors:
Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Organization:
College of American Pathologists
Accreditation status:
Recommended for clinical care, not required for accreditation
Intended use:
Reporting of biopsy specimens
Updates:
Optional reporting of largest invasive focus; revised lymphatic and/or vascular invasion terminology
Year:
2019
Region / city:
Not specified
Theme:
Oncology
Document type:
Clinical Protocol
Authors:
Erin Rudzinski, MD; Bruce Pawel, MD; Armita Bahrami, MD; M. John Hicks, MD
Target audience:
Healthcare professionals involved in pediatric oncology
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
February 2019
Version:
4.4.0.0
Protocol Posting Date:
March 2023
CAP Laboratory Accreditation Program Protocol Required Use Date:
December 2023
Year:
2023
Region / city:
N/A
Theme:
Thyroid carcinoma pathology
Document type:
Medical protocol
Institution:
CAP (College of American Pathologists)
Authors:
Ozgur Mete, MD; Sylvia L. Asa, MD, PhD; Zubair W. Baloch, MD; Lori Erickson, MD; Shereen Ezzat, MD; Lorne Rotstein, MD; Anna M. Sawka, MD, PhD; Raja R. Seethala, MD; Mark Zafereo, MD
Target audience:
Pathologists, oncology professionals
Period of validity:
Until December 2023
Date of approval:
March 2023
Date of amendments:
N/A
Version:
4.2.1.0
Protocol Posting Date:
June 2025
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2026
Year:
2025
Region / City:
Not specified
Subject:
Renal cell carcinoma, nephrectomy, tumor classification
Document Type:
Protocol
Institution:
CAP (College of American Pathologists)
Author:
Paari Murugan, MD, FCAP*, Robert W. Allan, MD, FCAP*, Lara R. Harik, MD, FCAP*
Target Audience:
Pathologists, medical professionals involved in cancer diagnostics
Effective Period:
March 2026 onward
Approval Date:
June 2025
Revision Date:
Not specified
Note:
Year
Subject:
Specimen Processing and Handling
Document Type:
SOP (Standard Operating Procedure)
Organization / Institution:
St. John’s Rehab Campus (SJRH)
Target Audience:
Healthcare staff, phlebotomists, laboratory technicians
Year:
[Insert Year]
Region / City:
Kampala
Topic:
Research Consent
Document Type:
Consent Form
Organization / Institution:
Infectious Diseases Institute
Author:
[Insert Author Name]
Target Audience:
Parents/Guardians of Study Participants
Period of Validity:
[Insert Period]
Approval Date:
[Insert Date]
Date of Amendments:
[Insert Date if applicable]
Year:
2016
Region / city:
UK
Topic:
Cellular pathology, Thyroid cytology
Document type:
Audit template
Organization / institution:
Royal College of Pathologists, British Association of Endocrine and Thyroid Surgeons (BAETS)
Author:
Not specified
Target audience:
Pathologists, Surgeons
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Note:
Year
Subject:
Cellular pathology, thyroid cytology
Document type:
Audit template
Organization / Institution:
The Royal College of Pathologists
Target audience:
Pathologists, endocrinologists, surgeons
Contextual description:
A clinical audit template for evaluating the accuracy of thyroid cytology reports in relation to histological findings, aimed at improving reporting practices in cellular pathology.
Note:
Year
Subject:
Blood Borne Virus Testing, HIV, Hepatitis B, Hepatitis C
Document Type:
Procedure
Organization / Institution:
Canberra Health Services
Target Audience:
Medical Officers, nurses, midwives, students under supervision
Version:
1.5.0.0
Protocol Posting Date:
June 2024
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2025
Authors:
Gulisa Turashvili, MD, PhD; Uma G. Krishnamurti, MD, PhD; Barbara A. Crothers, DO; Giovanna A. Giannico, MD; Krisztina Hanley, MD; Anna Plotkin, MD; Anthony N. Karnezis, MD, PhD.
Note:
Accreditation Requirements
Date of Protocol Posting:
June 2024
Date of Required Use:
March 2025
Year:
2021
Region / City:
United Kingdom
Subject:
Assistance Dogs, Emergency Ambulance Services
Document Type:
Procedure
Organization / Institution:
South East Coast Ambulance Service NHS Foundation Trust
Author:
Not specified
Target Audience:
Ambulance Service Staff
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Version:
NENC v2.0
Date published:
22 January 2026
Planned review date:
October 2027
Region:
North East and North Cumbria
Healthcare system:
NHS
Clinical area:
Neurology
Condition:
Amyotrophic lateral sclerosis
Medicine:
Riluzole
Document type:
Shared care protocol
Indication:
Extension of survival or time to mechanical ventilation in ALS
Target population:
Adults
Intended audience:
NHS healthcare professionals
Initiating authority:
Neurological specialist services
Regulatory reference:
NICE Technology Appraisal TA20
Prescribing setting:
Secondary to primary care transfer
Monitoring requirements:
Liver function tests, full blood count, urea and electrolytes
Route of administration:
Oral or enteral
Licensing status:
Licensed for ALS only